Novel SNP improves differential survivability and mortality in non-small cell lung cancer patients

BACKGROUND: Non-small cell lung cancer (NSCLC) is a major cause of cancer-related death worldwide due to poor patient prognosis and clinical outcome. Here, we studied the genetic variations underlying NSCLC pathogenesis based on their association to patient outcome after gemcitabine therapy. RESULTS...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMC Genomics
Autori principali: Mah, Tzia Liang, Yap, Xin Ning Adeline, Limviphuvadh, Vachiranee, Li, Nanpu, Sridharan, Srinath, Kuralmani, Vellaisemy, Feng, Mengling, Liem, Natalia, Adhikari, Sharmila, Yong, Wei Peng, Soo, Ross A, Maurer-Stroh, Sebastian, Eisenhaber, Frank, Tong, Joo Chuan
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2014
Soggetti:
Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4290611/
https://ncbi.nlm.nih.gov/pubmed/25521664
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2164-15-S9-S20
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi